Skip to main content
Top

Breast Cancer Research and Treatment

Issue 1/2005

Content (11 Articles)

Report

Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy

Martin D. Pickles, Martin Lowry, David J. Manton, Peter Gibbs, Lindsay W. Turnbull

Report

Effect of axillary lymphadenectomy on breast carcinoma survival

Sue A. Joslyn, Badrinath R. Konety

Report

Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy

Roza K. Sypniewska, Lieve Hoflack, Melissa Tarango, Susan Gauntt, Belinda Z. Leal, Robert L. Reddick, Claudia Gravekamp

Report

Effect of perductal paclitaxel exposure on the development of MNU-induced mammary carcinoma in female S–D rats

Homa Okugawa, Daigo Yamamoto, Yoshiko Uemura, Noriko Sakaida, Akihide Tanano, Kanji Tanaka, Yasuo Kamiyama

Report

Daily coordination of cancer growth and circadian clock gene expression

Shaojin You, Patricia A. Wood, Yin Xiong, Minoru Kobayashi, Jovelyn Du-Quiton, William J. M. Hrushesky

Report

Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer

L. Moureau-Zabotto, C. Bouchet, D. Cesari, S. Uzan, J.-P. Lefranc, M. Antoine, C. Genestie, E. Deniaud-Alexandre, J.-F. Bernaudin, E. Touboul, J. Fleury-Feith

Report

MTHFR genotypes and breast cancer survival after surgery and chemotherapy: a report from the Shanghai Breast Cancer Study

Martha J. Shrubsole, Xiao Ou Shu, Zhi Xian Ruan, Qiuyin Cai, Hui Cai, Qi Niu, Yu-Tang Gao, Wei Zheng

Report

Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related

Huei-Jean Huang, Patrick Neven, Maria Drijkoningen, Robert Paridaens, Hans Wildiers, Erik Van Limbergen, Patrick Berteloot, Frederic Amant, Marie Rose Christiaens, Ignace Vergote

Brief communication

Detection of genetic instability at HER-2/neu and p53 loci in breast cancer cells sing Comet–FISH

Tirukalikundram S Kumaravel, Robert G Bristow

Brief Communication

Sex cycle modulates cancer growth

Patricia A. Wood, William J.M. Hrushesky

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine